September 2026 Town Hall – What New JAK Treatment Breakthroughs Mean for Juvenile Myositis

Sept 16 Town Hall 2026

The treatment landscape for myositis is changing, with exciting new developments in targeted treatments called JAK inhibitors. Dr. Dawn Wahezi joined us for a special Cure JM Town Hall to learn what these treatments are, why they are generating so much interest, and what recent developments in adult dermatomyositis could mean for the future of our kids. Dr. Wahezi explained what families need to know about the potential benefits, risks, and future of this emerging treatment approach.

What is Juvenile Myositis?

Juvenile myositis, including juvenile dermatomyositis and juvenile polymyositis, is a group of rare and life-threatening autoimmune diseases, in which the body’s immune system attacks its own cells and tissues.

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.

Cure JM supports families, patients, and the juvenile myositis research community.

Interested in DIY fundraising but need help?

We’re here to help!

To have your fundraiser matched, add “DIY Match” in the memo of your online gift or check.